RAMON REYES: Open Payments
NPI 1811984727 · BOERNE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,014 in 67 payments from 14 companies in 2025. Trend: 2023 $2,784 · 2024 $5,855 · 2025 $8,014
Consulting: $4,080Food & beverage: $1,999Travel & lodging: $1,936
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 20 | $5,692 |
| Amgen Inc. | 13 | $1,651 |
| ABBVIE INC. | 12 | $206 |
| CeQur Corporation | 2 | $83 |
| Novo Nordisk Inc | 3 | $70 |
| Axsome Therapeutics, Inc. | 2 | $64 |
| PFIZER INC. | 5 | $46 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Exact Sciences Corporation | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
Products named: BREZTRI, FASENRA, VRAYLAR, REPATHA, CeQur Simplicity, Symbravo, TEZSPIRE, Ozempic.
Industry payments across TX — which companies pay providers there.
